Li Hua Zheng
Fundador en AnHeart Therapeutics (Hangzhou) Co., Ltd. .
Cargos activos de Li Hua Zheng
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Director/Miembro de la Junta | 27/11/2018 | - |
| Fundador | 27/11/2018 | - | |
| Corporate Officer/Principal | 27/11/2018 | - | |
| Anbio, Inc. | Director/Miembro de la Junta | 01/12/2017 | - |
| Fundador | 01/12/2017 | - | |
| Zheng & Karg LLP | Corporate Officer/Principal | 01/01/2018 | - |
Historial de carrera de Li Hua Zheng
Antiguos cargos conocidos de Li Hua Zheng.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Liu, Zheng, Chen & Hoffman LLP | Corporate Officer/Principal | 01/10/2015 | 01/12/2017 |
| UCOMMUNE INTERNATIONAL LTD | Director/Miembro de la Junta | 01/12/2018 | - |
| Independent Dir/Board Member | 01/12/2018 | - |
Formación de Li Hua Zheng.
| Fordham University School of Law | Graduate Degree |
| Baylor College of Medicine | Doctorate Degree |
| Fudan University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| China | 3 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Graduate Degree | 2 |
Sectorial
| Consumer Services | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Orisun Acquisition Corp.
 Orisun Acquisition Corp. Financial ConglomeratesFinance Orisun Acquisition Corp. is a blank check company, which engages in the provision of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more target businesses. The company was founded on October 22, 2018 and is headquartered in New York, NY. | Finance |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
| Anbio, Inc. | |
| Zheng & Karg LLP | |
| Liu, Zheng, Chen & Hoffman LLP |
- Bolsa de valores
- Insiders
- Li Hua Zheng
- Experiencia